-
March 3: The Week in Cancer NewsExercising only 11 minutes per day can reduce your cancer risk, and new robotic technology helps detect early-stage lung cancer.
by Thomas Celona
-
February 24: The Week in Cancer NewsAggressive end-of-life measures are common in people with advanced cancer in nursing homes, and findings suggest immune checkpoint inhibitors could one day be the preferred treatment in localized cancer.
by Marci A. Landsmann
-
February 17: The Week in Cancer NewsMore older women with breast cancer may not need radiation therapy, and supply shortages hinder bladder cancer treatment.
by Kevin McLaughlin
-
February 10: The Week in Cancer NewsPatients who receive certain forms of chemo face long-term risk for heart failure, and screening levels for certain cancers remain below expectations.
by Thomas Celona
-
February 3: The Week in Cancer NewsGroup says more women should consider removing fallopian tubes to lower ovarian cancer risk, and treatment guidelines can lead to arbitrary age cutoffs.
by Eric Fitzsimmons
-
January 27: The Week in Cancer NewsMany women underestimate dense breast effect on cancer risk, and FDA approves targeted therapy for colorectal cancer.
by Kevin McLaughlin
-
January 20: The Week in Cancer NewsWomen experience faster decline in physical function after cancer, and treatment quality for lung cancer varies across the US.
by Marci A. Landsmann
-
January 13: The Week in Cancer NewsWomen over 65 diagnosed at later stages of cervical cancer, and Black and Hispanic patients prescribed fewer opioids for end-of-life cancer care.
by Eric Fitzsimmons
-
January 6: The Week in Cancer NewsCancer patients have an increased risk of breakthrough COVID-19 infections, and CAR T-cell therapy is safe for lymphoma patients with HIV.
by Thomas Celona
-
December 16: The Week in Cancer NewsA second KRAS inhibitor is approved for lung cancer, and a BTK inhibitor challenges standard of care for relapsed or refractory CLL.
by Marci A. Landsmann
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
